Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Journal Sections
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Collections
      • COVID-19 & Cancer Resource Center
      • Precision Medicine and Therapeutic Resistance
      • Clinical Trials
      • Immuno-oncology
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
    • Journal Press Releases
  • COVID-19
  • Webinars
  • 10th Anniversary
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Discovery
Cancer Discovery
  • Home
  • About
    • The Journal
    • AACR Journals
    • Journal Sections
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Collections
      • COVID-19 & Cancer Resource Center
      • Precision Medicine and Therapeutic Resistance
      • Clinical Trials
      • Immuno-oncology
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
    • Journal Press Releases
  • COVID-19
  • Webinars
  • 10th Anniversary
  • Search More

    Advanced Search

Research Watch

Copy-Number Evolution Maintains Diversity during Breast Tumor Growth

DOI: 10.1158/2159-8290.CD-RW2021-050
  • Article
  • Info & Metrics
Loading
  • Major Finding: Cancer cells acquired chromosomal rearrangements and harbored a variety of subclones during tumor growth.

  • Approach: A novel single-molecule single-cell DNA-sequencing method was used to assess copy-number evolution.

  • Impact: This work supports a model in which tumor cells maintain subclonal diversity during tumor expansion.

Although many studies have investigated mechanisms that lead to aneuploidy and copy-number aberrations (CNA) in cancer, technical challenges with current methods have hindered analysis of copy-number evolution during tumor progression. To explore chromosome evolution in human triple-negative breast cancer (TNBC) tumors, Minussi, Nicholson, Ye, and colleagues developed a single-cell single-molecule DNA-sequencing method called acoustic cell tagmentation (ACT), a higher-throughput and cost-effective approach relative to many other single-cell DNA-sequencing protocols. ACT was implemented on eight human TNBC tumors (n = 9,765 cells), revealing that the tumor cells could be divided into 3 to 5 superclones that were each further divided into 7 to 22 subclones in each of the eight tumors. The ACT data was used to infer phylogenetic trees that represented evolution of clonal lineages in individual tumors and suggested that copy-number evolution continued to occur following the onset of primary tumor expansion. To evaluate models that describe ongoing CNA accumulation in tumor cells, mathematical modelling was applied, providing evidence for a process of CNA accumulation in which TNBC cells undergo an initial burst of genomic instability followed by a period of transient instability before returning to copy-number evolution at a baseline rate. The application of ACT was extended to human TNBC cell lines, in which the copy-number substructure was found to be representative of that of TNBC tumors. Notably, one TNBC cell line was subcloned into single daughter cells that were expanded for 19 cell doublings, revealing that tumor cells acquired about one CNA per four cell divisions and highlighting that isogenic subcloning can still lead to heterogeneous genotypes. In summary, this work not only describes a novel method of single-cell DNA-sequencing at high resolution but also provides evidence for a model in which breast cancer cells maintain subclonal diversity during primary tumor growth.

Minussi DC, Nicholson MD, Ye H, Davis A, Wang K, Baker T, et al. Breast tumours maintain a reservoir of subclonal diversity during expansion. Nature 2021 Mar 24 [Epub ahead of print].

Notes

Note: Research Watch is written by Cancer Discovery editorial staff. Readers are encouraged to consult the original articles for full details. For more Research Watch, visit Cancer Discovery online at http://cancerdiscovery.aacrjournals.org/CDNews.

  • ©2021 American Association for Cancer Research.
PreviousNext
Back to top

This OnlineFirst version was published on April 2, 2021
doi: 10.1158/2159-8290.CD-RW2021-050

View this article with LENS

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Discovery article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Copy-Number Evolution Maintains Diversity during Breast Tumor Growth
(Your Name) has forwarded a page to you from Cancer Discovery
(Your Name) thought you would be interested in this article in Cancer Discovery.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Copy-Number Evolution Maintains Diversity during Breast Tumor Growth
Cancer Discov April 2 2021 DOI: 10.1158/2159-8290.CD-RW2021-050

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Copy-Number Evolution Maintains Diversity during Breast Tumor Growth
Cancer Discov April 2 2021 DOI: 10.1158/2159-8290.CD-RW2021-050
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Notes
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Cell-Intrinsic Programs Partition Nutrients in Tumor Microenvironment
  • Extrachromosomal DNA Can Promote Oncogene Transcription in Trans
  • Transient Rest Reverses Exhaustion of Chimeric Antigen Receptor T Cells
Show more Research Watch
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • OnlineFirst
  • Current Issue
  • Past Issues

Info For

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Discovery

  • About the Journal
  • Editors
  • Journal Sections
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Discovery
eISSN: 2159-8290
ISSN: 2159-8274

Advertisement